Anastrozole use appears to increase the risk of bone mass loss

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1081, 2005-01, pp. : 5-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anastrozole-related bone loss "manageable"

By  

Reactions Weekly, Vol. 1, Iss. 1326, 2010-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Risedronic acid abrogates anastrozole-induced bone loss

By  

Inpharma, Vol. 1, Iss. 1620, 2008-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Infliximab use appears to increase the risk of heart disorders, including arrhythmias, in children with inflammatory bowel disease (IBD)

By  

Reactions Weekly, Vol. 1, Iss. 1117, 2006-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Infliximab use appears to increase the risk of heart disorders, including arrhythmias, in children with inflammatory bowel disease (IBD)

By  

Inpharma, Vol. 1, Iss. 1553, 2006-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Glitazones accelerate bone loss and increase the risk of fracture in patients with type 2 diabetes mellitus

By  

Drugs & Therapy Perspectives, Vol. 26, Iss. 1, 2010-01 ,pp. : 22-23

Adis International

Access to resources Recommend Favorite